Stocklytics Platform
Asset logo for symbol TMDX
TransMedics Group
TMDX71
$78.10arrow_drop_down1.55%-$1.23
Asset logo for symbol TMDX
TMDX71

$78.10

arrow_drop_down1.55%

Performance History

Chart placeholder
Key Stats
Open$77.20
Prev. Close$77.20
EPS0.93
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range76.75
80.89
52 Week Range36.42
177.37
Ratios
EPS0.93

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About TransMedics Group (TMDX)

TransMedics Group Inc. (TMDX) is a medical technology company that offers innovative solutions for the preservation, transportation, and assessment of organs for transplantation. The company's flagship product, the OCS Heart System, is a portable device that allows for the assessment and transportation of hearts for transplantation. With this system, physicians can evaluate and optimize the quality of a donor heart outside of the traditional static cold storage method. This allows for more hearts to be suitable for transplantation and potentially improves patient outcomes.
In addition to the OCS Heart System, TransMedics Group Inc. offers the OCS Lung and OCS Liver Systems, which provide similar benefits for the assessment and transportation of lungs and livers, respectively. These systems have the potential to revolutionize the field of organ transplantation by enabling the use of more organs and improving the quality of transplanted organs.
Sector
Healthcare
Industry
Medical Devices
CEO
Dr. Waleed H. Hassanein M.D.
Headquarters
Andover
Employees
212
Exchange
NASDAQ
add TransMedics Group  to watchlist

Keep an eye on TransMedics Group

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is TransMedics Group 's (TMDX) price per share?

The current price per share for TransMedics Group (TMDX) is $78.11. The stock has seen a price change of -$1.23 recently, indicating a -1.56% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for TransMedics Group (TMDX)?

For TransMedics Group (TMDX), the 52-week high is $177.37, which is 127.09% from the current price. The 52-week low is $36.42, the current price is 114.46% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is TransMedics Group (TMDX) a growth stock?

TransMedics Group (TMDX) has shown an average price growth of -7.23% over the past three years. It has received a score of 89 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying TransMedics Group as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is TransMedics Group (TMDX) stock price performance year to date (YTD)?

As of the latest data, TransMedics Group (TMDX) has a year-to-date price change of 1.7%. Over the past month, the stock has experienced a price change of -37.25%. Over the last three months, the change has been -54.84%. Over the past six months, the figure is -43.57%. Looking at a longer horizon, the five-year price change stands at 351.74%.
help

Is TransMedics Group (TMDX) a profitable company?

TransMedics Group (TMDX) has a net income of -$25.03M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 63.77% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 3.61% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $241.62M, although specific revenue growth data is currently not available. The gross profit is $154.09M. Operating income is noted at -$28.73M. Furthermore, the EBITDA is $64.28M.
help

What is the market capitalization of TransMedics Group (TMDX)?

TransMedics Group (TMDX) has a market capitalization of $2.66B. The average daily trading volume is 78.56, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level